跳至主要内容
临床试验/NCT02096484
NCT02096484已完成不适用

Group Metacognitive Therapy Versus Mindfulness Meditation Therapy in a Transdiagnostic Patient Sample: A Feasibility Study

University of Manchester2 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2014年8月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
40
试验地点
2
主要终点
Hospital Anxiety and Depression Scale (HADS)

研究概览

简要总结

The study will examine the effectiveness of group metacognitive therapy in comparison with group meditation therapy, in patients with Generalised Anxiety Disorder. Individuals will be randomly assigned to either meditation or metacognitive therapy and undergo 8 group therapy sessions of their respective treatment condition.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • individual's score on the GAD-7 & PHQ-9
  • individuals who meet the DSM-IV (Diagnostic and Statistical Manual) criteria for generalized anxiety disorder

排除标准

  • Individuals with major depressive disorder
  • Individuals who report suicidality
  • Individuals with a brain injury or neurological insult
  • Individual who currently engage in substance abuse
  • Individuals with bipolar disorder
  • Individuals with psychotic symptoms
  • Individuals who cannot converse or read English

结局指标

主要结局

Hospital Anxiety and Depression Scale (HADS)

时间窗: Administered at pre treatment, mid treatment, post treatment, and 6 month follow up

次要结局

  • CAS-I(Administered at pre treatment, mid treatment, post treatment, and 6 month follow up)
  • GAD-7(Completed prior to week 1 of treatment.This will be administered prior to treatment as a screening measure for levels of anxiety.)
  • PHQ-9(Completed prior to week 1 of treatment.This will be administered prior to treatment as a screening measure for levels of depression.)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Adrian Wells

Professor of Clinical & Experimental Psychopathology

University of Manchester

研究点 (2)

Loading locations...

相似试验